Blog

Physiomics plc (LSE:PYC) has secured a new agreement with Numab Therapeutics to provide pharmacokinetic/pharmacodynamic (PK/PD) modelling and simulation services for a First-In-Human clinical study within Numab’s inflammation pipeline. This partnership marks an important expansion for Physiomics, extending its Model-Informed Drug Development expertise beyond oncology into inflammatory diseases. The project is set to start shortly and is expected to complete within six months, reinforcing Physiomics’ commitment to supporting early-stage drug development decisions.

Despite this strategic collaboration, Physiomics continues to face financial headwinds, including falling revenues and ongoing losses. Technical analysis signals a bearish market outlook. While the new contract highlights growth potential, significant valuation challenges and financial instability remain key concerns for investors.

About Physiomics plc

Physiomics specializes in advanced mathematical modelling, biostatistics, and data science to accelerate the development of novel therapeutics and personalized medicine. With a track record of supporting over 100 commercial projects, the company partners with leading biopharma firms—including Merck KGaA, Astellas, Bicycle Therapeutics, Numab Therapeutics, and Cancer Research UK—to optimize drug development strategies through sophisticated simulation and analysis.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

KEFI Gold and Copper PLC (LSE:KEFI) has begun the community resettlement phase for its Tulu Kapi Gold Project in Ethiopia ahead of schedule, marking a key milestone as the company moves closer to full-scale operations. Funded through KEFI’s recent capital raise, this progress supports the target to commence gold production by 2027. The initiative enjoys strong backing from the Ethiopian government alongside major international gold investors.

About KEFI Minerals

KEFI Gold and Copper PLC specializes in the exploration and development of gold and copper assets within the Arabian-Nubian Shield region, with active projects located in both Ethiopia and Saudi Arabia.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Journeo plc (LSE:JNEO) has secured a £1.2 million contract via its Danish arm, Journeo AS, to supply Intelligent Transport Systems to Umove, Denmark’s largest private public transport operator. This project, tied to Umove’s 12-year partnership with Trafikselskabet Midttrafik, will see around 100 buses outfitted with cutting-edge technology such as passenger counting and AI-driven systems. The contract strengthens Journeo’s foothold in the Nordic transport market and supports its recurring revenue streams.

The company’s outlook is buoyed by solid financial results and strategic developments, signaling robust growth and expanding market reach. While technical analysis points to a bullish momentum, investors should remain cautious amid signs of potential overbought conditions. Valuation metrics remain attractive, underpinning Journeo’s investment potential.

About Journeo plc

Journeo is a leading provider of Intelligent Transport Systems, delivering advanced solutions for public transport networks, urban areas, airports, and rail. Operating through five subsidiaries, the company partners with local governments, Network Rail, and major transport operators in Denmark and Sweden, specializing in fleet management, passenger systems, rail technology, and technical services.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Creightons plc (LSE:CRL) has released its audited results for the fiscal year ending 31 March 2025, reporting a 1.6% rise in revenue to £54.1 million, largely driven by private label sales. Profitability saw a notable rebound, with EBITDA climbing 57.9% and the company returning to a £2.5 million post-tax profit—thanks to streamlined operations, cost controls, and efficiency gains in both manufacturing and distribution.

The company also confirmed its strategic transition from the Main Market to the AIM, aimed at reducing regulatory overheads and providing greater flexibility for growth initiatives. Governance practices are evolving accordingly, with new board appointments and the adoption of the QCA Corporate Governance Code to align with AIM standards.

Although revenue growth remains modest and technical indicators suggest the stock may be entering overbought territory, recent operational improvements and structural changes present a more optimistic longer-term outlook. Valuation concerns persist, but strong cash flow and strategic repositioning are likely to support future performance.

About Creightons plc

Creightons is a UK-based manufacturer and brand owner in the beauty and wellness sector. The company specializes in private label and contract manufacturing, alongside its own branded product lines, serving a broad range of retail and consumer clients.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cordel Group PLC (LSE:CRDL) has reported an 8% year-over-year revenue increase for the fiscal year ending June 2025, reaching £4.79 million. Improved operating margins and stronger cash flow were driven by a strategic shift toward high-margin software revenues and tighter cost control. Although some revenue from recent contracts has been delayed, Cordel secured five new clients, including two major U.S. rail operators, reinforcing its global footprint.

Looking ahead, the company is ramping up investment in marketing and delivery infrastructure to support the launch of its Positive Train Control (PTC) platform, which has attracted growing international attention.

While Cordel’s top-line growth and expanding market presence are encouraging, ongoing challenges with profitability and liquidity may concern long-term investors. Still, the company’s strategic moves and contract wins suggest a promising path forward.

About Cordel Group PLC

Cordel Group is a transport technology firm delivering advanced hardware and AI-powered software solutions for infrastructure monitoring. Specializing in corridor analytics, the company helps rail and transport operators make data-driven decisions through large-scale data capture and intelligent reporting tools.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Supply@ME Capital plc (LSE:SYME) has reported a delay in receiving a US$1.2 million tranche from its US$5.15 million on-demand convertible funding agreement with Nuburu Inc. The postponement stems from financial statement restatements by Nuburu, temporarily impacting SYME’s cash flow and near-term operational flexibility. Nuburu has indicated that it expects to release the pending funds shortly, and SYME has committed to keeping stakeholders informed once the payment is completed.

About Supply@ME Capital plc

Supply@ME is a fintech company offering a unique inventory monetisation platform. It enables manufacturers and trading firms to unlock working capital by converting inventory into liquidity, without taking on traditional debt. Through partnerships with third-party inventory funders, SYME provides alternative finance solutions designed to optimize balance sheets and support business growth.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Wynnstay Properties PLC (LSE:WSP) has delivered a strong first-quarter trading update ahead of its Annual General Meeting, reporting successful lease renewals and new lettings at increased rental rates. The company’s entire portfolio remains fully occupied, with solid tenant retention and no notable rent arrears, underscoring its stable operational performance and reinforcing confidence among stakeholders.

The outlook for Wynnstay remains favorable, driven by solid financials, effective property management, and value-enhancing strategic actions. With a healthy dividend yield and an appealing P/E ratio, the stock appears reasonably valued. While some technical indicators show mixed signals, they may also point to potential entry points. Investors are advised to keep an eye on technical movements and leverage metrics as part of ongoing evaluation.

About Wynnstay Properties PLC

Wynnstay Properties is a UK-based commercial property investment and management company. Focused on leasing and maintaining a diversified portfolio of commercial assets, the firm provides space for a range of tenants and continues to pursue long-term growth through active asset management.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Strip Tinning Holdings plc (LSE:STG) has secured £857,000 in government funding through the UK’s DRIVE35 initiative, administered by the Advanced Propulsion Centre. The grant will support Strip Tinning’s involvement in the Inter Connected Cell Assembly (ICCA) project, focused on developing advanced battery sensing and communication technologies for electric vehicles. The company will work alongside major partners including Jaguar Land Rover and Warwick Manufacturing Group. The 2.5-year project is scheduled to begin in the third quarter of 2025 and is aimed at accelerating the transition to net-zero automotive solutions.

Despite this strategic opportunity, Strip Tinning continues to grapple with financial and operational headwinds. Ongoing losses and weak valuation metrics underline a challenging business environment. While participation in the ICCA project signals innovation and growth potential, investors should remain cautious amid persistent financial uncertainty.

Company Overview – Strip Tinning Holdings plc

Strip Tinning Holdings plc specializes in supplying high-tech connection systems to the automotive industry. The company is known for its contributions to the development of next-generation electric vehicle technologies, despite facing current financial pressures.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

PureTech Health plc (LSE:PRTC) has announced a CEO transition, with Bharatt Chowrira stepping down and Robert Lyne stepping in as Interim Chief Executive. Lyne brings a strong background in life sciences and venture capital, and is expected to continue driving the company’s mission of advancing its pipeline and enhancing shareholder value. His leadership aims to maintain momentum across PureTech’s innovative programs focused on patient impact and long-term growth.

The company’s outlook remains cautiously optimistic. While recent earnings and valuation metrics point to possible undervaluation and strategic progress, operational challenges and muted market signals highlight the need for prudent execution going forward.

About PureTech Health

PureTech Health is a clinical-stage biotherapeutics company developing novel therapies for serious diseases. Its pipeline includes 29 therapeutic programs, three of which have received FDA approval. With a strong foundation in scientific innovation and collaboration, PureTech aims to deliver meaningful medical breakthroughs through its expansive R&D network.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

UBS Group AG has reduced its trading book position in Costain Group PLC (LSE:COST) to below the 5% threshold, removing the requirement for mandatory disclosure under UK market rules. This reduction suggests a strategic shift in UBS’s portfolio and may subtly alter Costain’s shareholder profile, with potential implications for investor sentiment and market dynamics.

Costain continues to demonstrate financial resilience, supported by strategic initiatives such as share repurchases and sustained investor confidence, including past backing from UBS. While technical indicators reflect strong upward momentum, signs of possible overbought conditions call for measured optimism. Favorable valuation metrics contribute to a stable and balanced investment outlook.

About Costain Group PLC

Costain Group is a UK-based infrastructure solutions provider, specializing in engineering services across key sectors including transport, water, and energy. The company focuses on delivering complex, mission-critical projects that support national infrastructure and sustainability goals.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.